Te Rārangi Rongoā Pharmaceutical Schedule
Pharmaceutical Schedule

All funded medicines in New Zealand.
Te pūtea me ngā umanga rongoā Medicine funding and supply
Medicine funding and supply

Ask us to fund a medicine | Check changes to medicines | How do generics work?
- Make an application
- Medicine notices (includes supply issues)
  
  Brand changes, discontinuations and more.
- The funding process
- What you need to know about medicines
- Medicine supply management
  
  Order condoms and nicotine replacement | About supply management
Ngā pūrere hauora a te hōhipere Hospital medical devices
Hospital medical devices

PHARMAC contracts with device suppliers to ensure our hospitals can buy medical devices at fairer prices.
- Category Information
  
  Medical devices we have contracted and the ones we're working on
- Growing our role in medical devices
- Device Advice
  
  Read and subscribe to our devices newsletter
Treaty of Waitangi Te Tiriti o Waitangi
Te Tiriti o Waitangi
- Te Whaioranga
  
  PHARMAC's Māori Responsiveness Strategy
- Hauora Arotahi
  
  The Māori health areas of focus
- Programmes to support Māori health
  
  Scholarships, awards and programmes
- How we work with Whānau Ora
Ngā karere me ngā rauemi News and resources
News and resources
- Consultations and decisions
  
  includes RFPs and tenders.
- News and updates
- Order publications
- Seminars
- COVID-19
- PHARMAC's research
- Uptake of medicines for type 2 diabetes
  
  Nearly 30,000 approved Special Authority applications.
Mō About
About
- Strategic Direction
  
  Our plan to deliver the best health outcomes for New Zealanders
- Pacific Responsiveness Strategy
- Te Tiriti o Waitangi
- What we do
- Who we are
- How we get expert advice
  
  Advice we seek to make decisions
- Working at Pharmac
  
  Explore current vacancies
- Contact us
  
  How to get in touch

Bupropion hydrochloride (Zyban): Stock issue resolved

Last Updated: 7 January 2021

7 January 2020: Stock of Zyban has arrived and been released from the supplier.

About the supply issue: In December 2020, GlaxoSmithKline, the supplier of Zyban, had to manage low stock levels caused by shipping delays.

About Zyban (bupropion hydrochloride)

Zyban is indicated for the treatment of nicotine dependence in adults aged 18 and older as an aid to smoking cessation.

Who to contact

If you have questions about supply of Zyban, we recommend you contact your wholesaler.

If you have questions about funding, contact PHARMAC:

email: enquiry@pharmac.govt.nz
phone: 0800 660 050